Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma [Phase 1, Phase 2]
Clinical trial evaluating Brentuximab Vedotin with Gemcitabine for younger patients with relapsed or refractory Hodgkin lymphoma completed, …
-
CLINICAL_TRIALS trial_result · 2019-08-05Clinical Trial Update: Molecular and Whole-body MR Imaging in Lymphomas [NA]
Completed clinical trial investigating molecular and whole-body MRI imaging methods in lymphoma patients; results were posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-19Clinical Trial Update: Clinical Efficacy of MOAP Regimen for Relapsed/Refractory cHL as a Rescue Therapy After DP Regimen [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating MOAP regimen as rescue therapy for relapsed/refractory Hodgkin lymphoma after DP regimen.
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 clinical trial evaluating autologous peripheral blood stem cell transplant followed by donor bone marrow transplant in high-risk B- …
-
CLINICAL_TRIALS trial_result · 2019-05-06Clinical Trial Update: Brentuximab Vedotin (Recombinant) for IV Infusion - Special Drug Use Surveillance (All-case Surveillance) "Relapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell Lymphoma"
Clinical trial update for brentuximab vedotin (Recombinant) in relapsed or refractory CD30+ Hodgkin's lymphoma or anaplastic large cell lymp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-04-02Clinical Trial Update: Clinical Application of Polyethylene Glycol Liposome Doxorubicin (PLD) in Primary Lymphoma [Phase 4]
Phase 4 clinical trial update evaluating polyethylene glycol liposome doxorubicin (PLD) for primary lymphoma (including Non-Hodgkin and Hodg…
-
CLINICAL_TRIALS trial_result · 2019-04-01Clinical Trial Update: SHR-1210 Alone or in Combination With Decitabine in Relapsed or Refractory Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating SHR-1210 alone or with decitabine in relapsed or refractory Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2019-03-27Clinical Trial Update: Autologous and Allogeneic Transplant for Relapsed Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial update on autologous and allogeneic transplant for relapsed lymphoma, completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-12Clinical Trial Update: Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas [Phase 2]
Phase 2 trial update of cellular immunotherapy targeting EBV in viral-induced cancers including various lymphomas; the study is terminated w…
-
CLINICAL_TRIALS trial_result · 2019-03-07Clinical Trial Update: A Study of Brentuximab Vedotin Combined With Nivolumab for Relapsed or Refractory Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating brentuximab vedotin in combination with nivolumab for relapsed or refractory Hodgkin lymphoma has completed with …
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Rituximab and Cyclophosphamide Followed by Vaccine Therapy in Treating Patients With Relapsed Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating rituximab and cyclophosphamide followed by vaccine therapy in relapsed Hodgkin lymphoma has completed with result…
-
CLINICAL_TRIALS trial_result · 2019-01-28Clinical Trial Update: Alisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell Lymphomas [Phase 1]
Phase 1 study of alisertib plus romidepsin in relapsed or refractory B-cell and T-cell lymphomas has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) [Phase 2]
Phase 2 study evaluating novel approaches to prevent graft-versus-host disease after allogeneic hematopoietic cell transplantation, with res…
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation [Phase 1]
Phase 1 trial evaluating inducible regulatory T cells (iTregs) in non-myeloablative sibling donor peripheral blood stem cell transplantation…
-
CLINICAL_TRIALS trial_result · 2018-12-11Clinical Trial Update: Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational) [Phase 2]
Phase 2 registrational trial of nivolumab in classical Hodgkin's lymphoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-27Clinical Trial Update: A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma [Phase 3]
A Phase 3 frontline therapy trial in advanced classical Hodgkin lymphoma has completed. Results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-21Clinical Trial Update: Reduced Intensity Double Umbilical Cord Blood Transplantation [Phase 2]
Phase 2 results for reduced-intensity double umbilical cord blood transplantation were completed and results posted in 2018. The study evalu…
-
CLINICAL_TRIALS trial_result · 2018-11-01Clinical Trial Update: Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-cell Lymphoma [Phase 2]
Phase 2 pilot study investigating ruxolitinib in relapsed or refractory Hodgkin lymphoma and primary mediastinal large B-cell lymphoma has c…
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy [Phase 3]
A Phase 3 trial evaluating prophylactic use of Filgrastim SD/01 in Hodgkin disease patients undergoing ABVD chemotherapy has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-29Clinical Trial Update: Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial update evaluating targeted BEACOPP variants in newly diagnosed advanced classical Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-09-04Clinical Trial Update: Radiolabeled Monoclonal Antibody and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With High-Risk Lymphoid Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating a radiolabeled monoclonal antibody with combination chemotherapy before stem cell transplant in high-ris…
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Pilot Study of Abbreviated Chemotherapy Based on Positron Emission Tomography (PET) Scan in Hodgkin's Lymphoma [NA]
Pilot study evaluating abbreviated chemotherapy guided by PET scans in Hodgkin's lymphoma was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2018-08-22Clinical Trial Update: A Phase II Study of Oral JAK1/JAK2 Inhibitor INC424 in Adult Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma [Phase 2]
Phase II study of oral JAK1/JAK2 inhibitor INC424 in adults with relapsed/refractory classical Hodgkin's lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy followed by bone marrow or stem cell transplantation in refractory Hodgkin's dise…
-
CLINICAL_TRIALS trial_result · 2018-08-01Clinical Trial Update: Safety and Efficacy Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma [Phase 1, Phase 2]
Clinical trial update on safety and efficacy of I-131 tositumomab in relapsed/refractory Hodgkin's lymphoma (Phase 1/Phase 2; completed).